retatrutide cagrilintide vs CagriSema: The Battle Nobody's Covering Cagrilintide, Tirzepatide, and Retatrutide Peptides:

However, this effect is significantly diminished or absent in diabetes

Oral semaglutide has been found to improve fasting blood glucose levels in a trial conducted over a 12 week period with improved levels of triglycerides, very low-density lipoprotein (VLDL), low- density lipoprotein (LDL) and apolipoprotein B48 (ApoB48) and no change in high density lipoprotein (HDL) (61)

Impact on perioperative glycaemia Less hypoglycaemia risk than insulin and better perioperative glucose control

You can read the full article at Cardiovascular risk reduction with once-weekly semaglutide in subjects with type 2 diabetes: a post hoc analysis of gender, age, and baseline CV risk profile in the SUSTAIN 6 trial PMC (nih.gov)

Moreover, Resmetirom, a thyroid hormone beta receptor agonist, has recently been approved for MASLD treatment